ArticleNature biomedical engineering2026
Learning neuroimaging models from health system-scale data.
Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- NeuroRAD-FM: A Distributionally Robust Foundation Model for Precision Neuro-Oncology.Research square · 2026Article
- Health system learning enables generalist neuroimaging models.Nature medicine · 2026Article
- NeuroFM: Toward Precision Neuroimaging with Foundation Models for Individualized Brain Health Estimation.medRxiv : the preprint server for health sciences · 2026Article
- Health system learning achieves generalist neuroimaging models.Research square · 2025Article
- Intelligent histology for tumor neurosurgery.Neuro-oncology advancesReview
Corrections and comments
- Update of
Authors and funding
21 authors.
Funding
Abstract
Neuroimaging is a ubiquitous tool for evaluating patients with neurological diseases. The global demand for magnetic resonance imaging (MRI) studies has risen steadily, placing substantial strain on health systems, prolonging turnaround times and intensifying physician burnout. These challenges disproportionately impact patients in low-resource and rural settings. Here we utilize data from a large academic health system to develop Prima, an AI foundation model for neuroimaging that supports real-world, clinical MRI studies as input. Trained on over 220,000 MRI studies, Prima uses a hierarchical vision architecture that provides general and transferable MRI features. Prima was tested in a 1-year health system-wide study that included 29,431 MRI studies. Across 52 radiologic diagnoses from major neurologic disorders, Prima achieved a mean diagnostic area under the curve (AUC) of 92.0%, outperforming other state-of-the-art general and medical AI models. Prima offers explainable differential diagnoses, worklist priority for radiologists and clinical referral recommendations. Prima demonstrates algorithmic fairness across sensitive groups. These findings highlight the transformative potential of health system-scale AI training and Prima's role in advancing AI-driven healthcare.
Indexed as
Identifiers
41652068What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.